Skip to main content
Clinical Trials/NCT04384978
NCT04384978
Completed
Not Applicable

Development of Serious Games and Physical Activities Instructed by a Social Robot for Improving the Well-being of Elderly Individuals With Alzheimer's Disease and Dementia

DreamFace Technologies, LLC1 site in 1 country22 target enrollmentJanuary 12, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer Disease
Sponsor
DreamFace Technologies, LLC
Enrollment
22
Locations
1
Primary Endpoint
Change in Cognitive/Memory Ability
Status
Completed
Last Updated
last year

Overview

Brief Summary

A 12-month pilot study will be comprised of two groups of people diagnosed with mild Alzheimer's disease and related dementia for a total of 80 senior subjects. Subjects will be randomly assigned to two groups: Group 1 users will play games with and administered by Ryan, 2-3 times a week and 30-minutes per day. Group 2 (Active Control Group) will play solitary games and activities but will have to interaction with Ryan. The team will measure the changes and improvement in the social/emotional well-being of these two groups and eventual changes in the cognitive/memory functions of elderly people living in the similar environment.

Registry
clinicaltrials.gov
Start Date
January 12, 2020
End Date
April 15, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
DreamFace Technologies, LLC
Responsible Party
Principal Investigator
Principal Investigator

Mohammad Mahoor

Founder and CEO

DreamFace Technologies, LLC

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Aggressive behavior
  • Diagnosed with severe dementia or memory loss
  • Acute physical illness that impairs ability to participate
  • Patients with serious comorbidity, tumors and other diseases casually related to cognitive impairment
  • History of alcohol or drug abuse, head trauma, psychoactive substance use and other causes of memory impairment
  • Significant sensory impairment

Outcomes

Primary Outcomes

Change in Cognitive/Memory Ability

Time Frame: assessed at baseline (week 1), week 4, and 8. Week 8 reported.

Participants will complete the Saint Louis University Mental Status (SLUMS) test, a screening method for Alzheimer's and other dementia. Scores range from 0 to 30. Scores of 27 to 30 are considered normal in a person with a high school education. Scores between 21 and 26 suggest a mild neurocognitive disorder. Scores between 0 and 20 indicate dementia.

Study Sites (1)

Loading locations...

Similar Trials